ArticleMolecular pharmacology2009

KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells.

Shary N Shelton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.